Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5543

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn ; volume:42 ; number:6 ; day:22 ; month:2 ; year:2022 ; pages:702-707 ; date:6.2022
Journal of perinatology ; 42, Heft 6 (22.2.2022), 702-707, 6.2022

Creator: Teng, Jonas
Wickman, Linnéa
Reilly, Marie
Nemeth, Antal
Fischler, Björn
Bohlin, Kajsa
Tiblad, Eleonor

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41372-022-01345-1

URN: urn:nbn:de:101:1-2022080607410276207437

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Teng, Jonas
Wickman, Linnéa
Reilly, Marie
Nemeth, Antal
Fischler, Björn
Bohlin, Kajsa
Tiblad, Eleonor
SpringerLink (Online service)

Other Objects (12)

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Identifying Hemolytic Disease of the Fetus and Newborn within a Large Integrated Health Care System

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

Hemolytic disease of the fetus and newborn caused by anti-D and anti-S alloantibodies: a case report

Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody

Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Infections of the Fetus and Newborn Infant

In Response: Hemolytic Disease of the Fetus and Newborn: Understanding the Testing Needed to Confirm the Identity of the Causative Antibody

Physiology of the ductus arteriosus in the fetus and newborn

Related objects

Reset password